Immunocore Holdings stock forecast
Want to see IMCR full AI Analyst Report?
Immunocore Holdings (IMCR) Stock Forecast & Price Target
IMCR Analyst Ratings
IMCR Stock 12 Month Forecast
Average Price Target
$56.80▲(89.71% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Sean Laaman | Morgan Stanley | $43→$42 | hold | 40.28%Upside | Assigned | 11/13/26 | ||
| Rajan Sharma | Goldman Sachs | $74→$79 | buy | 163.86%Upside | Reiterated | 11/12/26 | ||
| Patrick Trucchio | H.C. Wainwright | $100→$80 | buy | 167.20%Upside | Reiterated | 11/10/26 | ||
| Graig Suvannavejh | Mizuho Securities | $35→$33 | hold | 10.22%Upside | Reiterated | 10/29/26 | ||
| Jessica Fye | J.P. Morgan | $50 | buy | 67.00%Upside | Initiated | 08/21/26 | ||
| Gil Blum | Needham | $75 | buy | 150.50%Upside | Reiterated | 08/06/26 | ||
| Tyler Van Buren | TD Cowen | $60 | buy | 100.40%Upside | Reiterated | 05/06/26 | ||
| Guggenheim | ― | hold | ― | Reiterated | 05/06/26 | |||
| Eva Fortea Verdejo | Wells Fargo | $60 | buy | 100.40%Upside | Reiterated | 04/14/26 | ||
| Faisal Khurshid | Jefferies | $33 | hold | 10.22%Upside | Downgraded | 03/15/26 | ||
| Michael Yee | UBS | $55 | buy | 83.70%Upside | Initiated | 01/06/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Sean LaamanMorgan Stanley | HoldAssigned$43→$42 | 11/13/26 | 40.28%Upside | ||
| Rajan SharmaGoldman Sachs | BuyReiterated$74→$79 | 11/12/26 | 163.86%Upside | ||
| Patrick TrucchioH.C. Wainwright | BuyReiterated$100→$80 | 11/10/26 | 167.20%Upside | ||
| Graig SuvannavejhMizuho Securities | HoldReiterated$35→$33 | 10/29/26 | 10.22%Upside | ||
| Jessica FyeJ.P. Morgan | BuyInitiated$50 | 08/21/26 | 67.00%Upside | ||
| Gil BlumNeedham | BuyReiterated$75 | 08/06/26 | 150.50%Upside | ||
| Tyler Van BurenTD Cowen | BuyReiterated$60 | 05/06/26 | 100.40%Upside | ||
| HoldReiterated | 05/06/26 | ― | |||
| Eva Fortea VerdejoWells Fargo | BuyReiterated$60 | 04/14/26 | 100.40%Upside | ||
| Faisal KhurshidJefferies | HoldDowngraded$33 | 03/15/26 | 10.22%Upside | ||
| Michael YeeUBS | BuyInitiated$55 | 01/06/26 | 83.70%Upside |
Best Analysts Covering Immunocore Holdings
Copying Gil Blum's trades and holding each position for 3 Months would result in 47.62% of your transactions generating a profit, with an average return of -2.26% per trade.
Copying Jessica Fye's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +7.70% per trade.
Copying Jessica Fye's trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -0.28% per trade.
IMCR Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 7 | 5 | 4 | 5 | 5 |
| Buy | 0 | 1 | 1 | 2 | 1 |
| Hold | 2 | 2 | 2 | 4 | 5 |
| Sell | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 9 | 8 | 11 | 11 |
In the current month, IMCR has received 6 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. IMCR average Analyst price target in the past 3 months is 56.80.
IMCR Financial Forecast
IMCR Earnings Forecast
Next quarter’s earnings estimate for IMCR is -$0.20 with a range of -$0.44 to $0.01. The previous quarter’s EPS was -$0.28. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
IMCR Sales Forecast
Next quarter’s sales forecast for IMCR is $112.23M with a range of $104.78M to $119.40M. The previous quarter’s sales results were $102.17M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

